Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

0.5056
-0.0044-0.86%
Volume:1.85M
Turnover:943.03K
Market Cap:82.23M
PE:-0.39
High:0.5309
Open:0.4968
Low:0.4952
Close:0.5100
Loading ...
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 13, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2022

Major Issues Report

8-K - Current report
Dec 07, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 01, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership